Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Cash Flow Quality Index
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Cash Flow Quality Index of 71.88x as of September 2025. Operating cash flow of CN¥153.30 Million exceeds net income of CN¥2.13 Million, indicating high earnings quality where cash backs reported profits. Explore Tianjin Chase Sun Pharmaceutical Co Ltd (300026) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tianjin Chase Sun Pharmaceutical Co Ltd Cash Flow Quality Index (2006–2024)
Historical Cash Flow Quality Index for Tianjin Chase Sun Pharmaceutical Co Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300026 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Year-by-year earnings quality comparison for Tianjin Chase Sun Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 300026 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 37.14x | CN¥852.24 Million | CN¥22.95 Million | ▲ +1117.5% |
| 2023 | 3.05x | CN¥1.53 Billion | CN¥501.57 Million | ▲ +154.2% |
| 2022 | 1.20x | CN¥745.35 Million | CN¥620.97 Million | ▲ +105.6% |
| 2021 | 0.58x | CN¥391.60 Million | CN¥670.85 Million | ▲ +66.1% |
| 2020 | 0.35x | CN¥196.66 Million | CN¥559.68 Million | ▼ -33.6% |
| 2019 | 0.53x | CN¥216.10 Million | CN¥408.43 Million | ▼ -70.6% |
| 2018 | 1.80x | CN¥388.19 Million | CN¥215.91 Million | ▲ +8.3% |
| 2017 | 1.66x | CN¥742.38 Million | CN¥447.21 Million | ▲ +144.9% |
| 2016 | 0.68x | CN¥448.08 Million | CN¥661.08 Million | ▲ +200.4% |
| 2015 | 0.23x | CN¥121.00 Million | CN¥536.23 Million | ▼ -32.4% |
| 2014 | 0.33x | CN¥149.94 Million | CN¥448.94 Million | ▼ -20.7% |
| 2013 | 0.42x | CN¥143.60 Million | CN¥340.90 Million | ▼ -27.9% |
| 2012 | 0.58x | CN¥152.21 Million | CN¥260.68 Million | ▲ +147.2% |
| 2011 | 0.24x | CN¥35.64 Million | CN¥150.91 Million | ▼ -42.1% |
| 2010 | 0.41x | CN¥46.25 Million | CN¥113.35 Million | ▼ -75.5% |
| 2009 | 1.67x | CN¥135.06 Million | CN¥80.97 Million | ▲ +38.2% |
| 2008 | 1.21x | CN¥77.74 Million | CN¥64.39 Million | ▼ -34.4% |
| 2007 | 1.84x | CN¥72.01 Million | CN¥39.16 Million | ▲ +1005.9% |
| 2006 | 0.17x | CN¥1.22 Million | CN¥7.36 Million | — |